UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 643

Sortiert nach

Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia

Clinical microbiology and infection, 2006-05, Vol.12 (s3), p.31-41

File, T.M.

2006

Volltextzugriff (PDF)

A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia

Antimicrobial Agents and Chemotherapy, 1997-09, Vol.41 (9), p.1965-1972

1997

Volltextzugriff (PDF)

Community-Acquired Pneumonia in Adults: Guidelines for Management

Clinical infectious diseases, 1998-04, Vol.26 (4), p.811-838

1998

Volltextzugriff (PDF)

Respiratory Syncytial Virus Is an Important Cause of Community-Acquired Lower Respiratory Infection among Hospitalized Adults

The Journal of infectious diseases, 1996-09, Vol.174 (3), p.456-462

1996

Volltextzugriff (PDF)

Can Aggressive Treatment of Diabetic Foot Infections Reduce the Need for Above-Ankle Amputation?

Clinical infectious diseases, 1996-08, Vol.23 (2), p.286-291

1996

Volltextzugriff (PDF)

Double-Blind, Randomized Study of the Efficacy and Safety of Oral Pharmacokinetically Enhanced Amoxicillin-Clavulanate (2,000/125 Milligrams) versus Those of Amoxicillin-Clavulanate (875/125 Milligrams), Both Given Twice Daily for 7 Days, in Treatment of Bacterial Community-Acquired Pneumonia in Adults

Antimicrobial Agents and Chemotherapy, 2004-09, Vol.48 (9), p.3323-3331

2004

Volltextzugriff (PDF)

Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin

Journal of antimicrobial chemotherapy, 2001-07, Vol.48 (1), p.67-74

2001

Volltextzugriff (PDF)

Multicenter, Open-Label, Randomized Study to Compare the Safety and Efficacy of Levofloxacin versus Ceftriaxone Sodium and Erythromycin Followed by Clarithromycin and Amoxicillin- Clavulanate in the Treatment of Serious Community-Acquired Pneumonia in Adults

Clinical infectious diseases, 2004-01, Vol.38 (Supplement-1), p.S16-S23

2004

Volltextzugriff (PDF)

Accuracy of ICD-9-CM Codes in Detecting Community-acquired Pneumococcal Pneumonia for Incidence and Vaccine Efficacy Studies

American journal of epidemiology, 1999-02, Vol.149 (3), p.282-289

1999

Volltextzugriff (PDF)

Overview of Resistance in the 1990s

Chest, 1999-03, Vol.115 (3), p.3S-8S

File, Thomas M.

1999

Volltextzugriff (PDF)

Reevaluation of the Definition of Legionnaires' Disease: Use of the Urinary Antigen Assay

Clinical infectious diseases, 1995-05, Vol.20 (5), p.1286-1291

1995

Volltextzugriff (PDF)

Parainfluenza Virus Infection Among Adults Hospitalized for Lower Respiratory Tract Infection

Clinical infectious diseases, 1999-07, Vol.29 (1), p.134-140

1999

Volltextzugriff (PDF)

Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study—authors' response

Journal of antimicrobial chemotherapy, 2007-10, Vol.60 (4), p.903-903

2007

Volltextzugriff (PDF)

Emergence of Levofloxacin-Resistant Pneumococci in Immunocompromised Adults after Therapy for Community-Acquired Pneumonia

Clinical infectious diseases, 2003-08, Vol.37 (3), p.376-381

2003

Volltextzugriff (PDF)

Spread of Serious Disease—Producing M3 Clones of Group A Streptococcus Among Family Members and Health Care Workers

Clinical infectious diseases, 1996-03, Vol.22 (3), p.490-495

1996

Volltextzugriff (PDF)

Clinical Characteristics of Chlamydia pneumoniae Infection as the Sole Cause of Community-Acquired Pneumonia

Clinical infectious diseases, 1999-08, Vol.29 (2), p.426-428

1999

Volltextzugriff (PDF)

Group A streptococcal necrotizing fasciitis. Diagnosing and treating the "flesh-eating bacteria syndrome"

Cleveland Clinic journal of medicine, 1998-05, Vol.65 (5), p.241-249

1998

Volltextzugriff (PDF)

Persistently Positive Culture Results in a Patient with Community-Acquired Pneumonia Due to Legionella pneumophila

Clinical infectious diseases, 2001-06, Vol.32 (11), p.1562-1566

2001

Volltextzugriff (PDF)

THE ROLE OF ATYPICAL PATHOGENS: MYCOPLASMA PNEUMONIAE, CHLAMYDIA PNEUMONIAE, AND LEGIONELLA PNEUMOPHILA IN RESPIRATORY INFECTION

Infectious disease clinics of North America, 1998-09, Vol.12 (3), p.569-592

1998

Volltextzugriff (PDF)

Treatment of skin and soft-tissue infections

The American journal of surgery, 1995-05, Vol.169 (5A Suppl), p.27S-33S

1995

Volltextzugriff (PDF)

Ofloxacin versus standard therapy in treatment of community-acquired pneumonia requiring hospitalization

Antimicrobial agents and chemotherapy, 1996, Vol.40 (5), p.1175-1179

1996

Volltextzugriff (PDF)

Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial

Archives of internal medicine (1960), 2000-05, Vol.160 (9), p.1294

2000

Volltextzugriff (PDF)

Rapid detection of Streptococcus pneumoniae in community-acquired pneumonia

Clinical microbiology and infection, 2006-12, Vol.12, p.27-33

2006

Volltextzugriff (PDF)

An outbreak of Pseudomonas aeruginosa ventilator-associated respiratory infections due to contaminated food coloring dye--further evidence of the significance of gastric colonization preceding nosocomial pneumonia

Infection control and hospital epidemiology, 1995-07, Vol.16 (7), p.417

1995

Volltextzugriff (PDF)

Pharmacokinetics of imipenem in serum and skin window fluid in healthy adults after intramuscular or intravenous administration

Antimicrobial Agents and Chemotherapy, 1992-07, Vol.36 (7), p.1400-1403

1992

Volltextzugriff (PDF)

1 – 25 von 643

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(528)
Mit Volltextzugriff
(547)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(356)
Life Sciences & Biomedicine
(332)
Humans
(294)
Biological And Medical Sciences
(160)
Male
(158)
Female
(147)
Infectious Diseases
(144)
Medical Sciences
(144)
Adult
(127)
Microbiology
(108)
Middle Aged
(100)
Pharmacology & Pharmacy
(89)
Immunology
(84)
Pharmacology. Drug Treatments
(82)
Anti-Bacterial Agents - Therapeutic Use
(79)
Aged
(77)
Pneumonia
(67)
Animals
(59)
Community-Acquired Infections - Drug Therapy
(58)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(53)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia

A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia

Community-Acquired Pneumonia in Adults: Guidelines for Management

Respiratory Syncytial Virus Is an Important Cause of Community-Acquired Lower Respiratory Infection among Hospitalized Adults

Can Aggressive Treatment of Diabetic Foot Infections Reduce the Need for Above-Ankle Amputation?

Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin

Multicenter, Open-Label, Randomized Study to Compare the Safety and Efficacy of Levofloxacin versus Ceftriaxone Sodium and Erythromycin Followed by Clarithromycin and Amoxicillin- Clavulanate in the Treatment of Serious Community-Acquired Pneumonia in Adults

Accuracy of ICD-9-CM Codes in Detecting Community-acquired Pneumococcal Pneumonia for Incidence and Vaccine Efficacy Studies

Overview of Resistance in the 1990s

Reevaluation of the Definition of Legionnaires' Disease: Use of the Urinary Antigen Assay

Parainfluenza Virus Infection Among Adults Hospitalized for Lower Respiratory Tract Infection

Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study—authors' response

Emergence of Levofloxacin-Resistant Pneumococci in Immunocompromised Adults after Therapy for Community-Acquired Pneumonia

Spread of Serious Disease—Producing M3 Clones of Group A Streptococcus Among Family Members and Health Care Workers

Clinical Characteristics of Chlamydia pneumoniae Infection as the Sole Cause of Community-Acquired Pneumonia

Group A streptococcal necrotizing fasciitis. Diagnosing and treating the "flesh-eating bacteria syndrome"

Persistently Positive Culture Results in a Patient with Community-Acquired Pneumonia Due to Legionella pneumophila

THE ROLE OF ATYPICAL PATHOGENS: MYCOPLASMA PNEUMONIAE, CHLAMYDIA PNEUMONIAE, AND LEGIONELLA PNEUMOPHILA IN RESPIRATORY INFECTION

Treatment of skin and soft-tissue infections

Ofloxacin versus standard therapy in treatment of community-acquired pneumonia requiring hospitalization

Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial

Rapid detection of Streptococcus pneumoniae in community-acquired pneumonia

An outbreak of Pseudomonas aeruginosa ventilator-associated respiratory infections due to contaminated food coloring dye--further evidence of the significance of gastric colonization preceding nosocomial pneumonia

Pharmacokinetics of imipenem in serum and skin window fluid in healthy adults after intramuscular or intravenous administration

Suchergebnisse filtern